Emmanuel Kolawole Oke

Patents, Human Rights, and Access to Medicines (eBook, PDF)

• Format: PDF

Produktbeschreibung

Patent rights on pharmaceutical products are one of the factors responsible for the lack of access to affordable medicines in developing countries. In this work, Emmanuel Kolawole Oke provides a systematic analysis of the tension between patent rights and human rights law, contending that, in order to preserve their patent policy space and secure access to affordable medicines for their citizens, developing countries should incorporate a model of human rights into the design, implementation, interpretation, and enforcement of their national patent laws. Through a comprehensive analysis of court decisions from three key developing countries (India, Kenya, and South Africa), Oke assesses the effectiveness of national courts in resolving conflicts between patent rights and the right to health, and demonstrates how a model of human rights can be incorporated into the adjudication of patent rights.

---

Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.

Produktdetails

• Verlag: Cambridge University Press (Virtual Publishing)
• Erscheinungstermin: 16. Februar 2022
• ISBN-13: 9781108581684
• Artikelnr.: 70912231

Autorenporträt

Emmanuel Kolawole Oke is a Lecturer in International Intellectual Property Law at Edinburgh Law School, University of Edinburgh. His research explores the interface between intellectual property and other branches of international law such as international trade law, international investment law, and international human rights law.

Inhaltsangabe

1. Introduction; 2. Patent Policy, Access to Medicines, and the Regulatory
Theory of Patent Rights; 3. The Interface between Patent Rights and the
Right to Health under International Human Rights Law; 4. Incorporating a
Model of Human Rights into the Adjudication of Pharmaceutical Patent Cases
(Part One): Kenya as a Case Study; 5. Incorporating a Model of Human Rights
into the Adjudication of Pharmaceutical Patent Cases (Part Two): South
Africa as a Case Study; 6. Incorporating a Model of Human Rights into the
Adjudication of Pharmaceutical Patent Cases (Part Three): India as a Case
Study; Conclusion.